Skip to main content
OpenTrials

Clinical trial condition

Biochemical Recurrence of Malignant Neoplasm of Prostate

Explore clinical trials studying Biochemical Recurrence of Malignant Neoplasm of Prostate. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Biochemical Recurrence of Malignant Neoplasm of Prostate trial results

Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT07483658

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Digestive System Diseases, Female Urogenital Diseases, +22 more
Locations
  • Gatineau Hospital Gatineau, Quebec, Canada
  • Hôpital Général Juif Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
  • CHU de Québec-Université Laval Québec, Quebec, Canada
View Trial Details
Recruiting

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

NCT05847348

Conditions
BCR Prostate Carcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate, Genital Diseases, +10 more
Locations
  • Peking University First Hospital Beijing, China
  • Xiangya Hospital Central South University Changsha, China
  • Nanfang Hospital Southern Medical University Guangzhou, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View Trial Details
Completed

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

NCT06235099

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Tower Urology Los Angeles, California, United States
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 31 locations
View Trial Details
Completed

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

NCT05407311

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate
Locations
  • Tower Urology Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Biogenix Molecular Miami, Florida, United States
  • Bamf Health, Inc Grand Rapids, Michigan, United States
View Trial Details
Completed

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

NCT05249127

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate
Locations
  • Tower Urology Los Angeles, California, United States
  • GU Research Network Omaha, Nebraska, United States
  • New Mexico Cancer Center Albuquerque, New Mexico, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions